Discovery of a small-molecule NDR1 agonist for prostate cancer therapy
Cited by 2
Related Papers
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer
|Oncotarget|2015|35
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir
|Journal of Viral Hepatitis|2019|34
TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
|Cell Death and Disease|2022|32
Alisol B 23-Acetate Inhibits IgE/Ag-Mediated Mast Cell Activation and Allergic Reaction
|International Journal of Molecular Sciences|2018|22